首页> 外国专利> METHOD FOR EVALUATING HUMAN BLASTOCYST BY NOREPINEPHRINE LEVEL IN BLASTOCYST CULTURE SOLUTION

METHOD FOR EVALUATING HUMAN BLASTOCYST BY NOREPINEPHRINE LEVEL IN BLASTOCYST CULTURE SOLUTION

机译:藻细胞培养液中去甲肾上腺素水平评估人胚细胞的方法

摘要

The invention provides a new method for evaluating transfer embryos including blastocysts used for in vitro fertilization in fertility treatment, and a method for evaluating transfer embryos using a new biomarker necessary for evaluation. The method comprises the steps of (a) providing a test object, for example, a culture solution of a human blastocyst, containing norepinephrine (noradrenaline) released from a transfer embryo, such as a human blastocyst, obtained from a subject; (b) quantitatively analyzing norepinephrine in the test object by a combination of ultra high performance liquid chromatography and mass spectrometry or the like; (c) predicting the quality of the transfer embryo based on the amount of norepinephrine from analysis results obtained; and (d) transferring the embryo into a suitable female recipient for implantation, if the transfer embryo is predicted to be of good quality and/or to lead to the establishment of a viable pregnancy based on step (c).
机译:本发明提供了用于评估包括在生殖治疗中用于体外受精的胚泡在内的移植胚胎的新方法,以及使用评估所需的新生物标记物评估移植胚胎的方法。该方法包括以下步骤:(a)提供测试对象,例如人胚泡的培养液,其含有从受试者获得的从移植胚例如人胚泡释放的去甲肾上腺素(去甲肾上腺素); (b)结合超高效液相色谱法和质谱法等对被检物中的去甲肾上腺素进行定量分析; (c)根据获得的分析结果中去甲肾上腺素的量预测移植胚胎的质量; (d)如果根据步骤(c)预计转移的胚胎质量良好和/或导致可行的怀孕,则将其转移至合适的雌性受体中进行植入。

著录项

  • 公开/公告号US2014249363A1

    专利类型

  • 公开/公告日2014-09-04

    原文格式PDF

  • 申请/专利权人 NAOKI YAMASHITA;

    申请/专利号US201314041338

  • 发明设计人 NAOKI YAMASHITA;KUMIKO NAKATA;

    申请日2013-09-30

  • 分类号G01N33/50;A61B17/435;

  • 国家 US

  • 入库时间 2022-08-21 16:07:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号